A study published in Neurology looks at the association between high fat cheese and dementia risk. Dr Richard Oakley, Associate Director of Research and Innovation at Alzheimer’s Society, said: ...
The drop reflects investors reactions to Pfizer’s new 2026 revenue forecasts, which is set to be between the range of $59.5 billion to $62.5 billion, a decline of $1.5 billion from 2025’s estimated ...
While you're collecting healthy dividends, you'll also benefit from the price-to-earnings (P/E) ratio expanding when revenue ...
In this week’s edition of InnovationRx, we look at French healthtech Doctolib’s potential large secondary round, Alice ...
Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
Pfizer’s shares, after a year of modest growth, recently fell following a cautious outlook for 2026, emphasizing ongoing ...
Zacks Investment Research on MSN
Pfizer issues soft 2026 view: What does it mean for the stock's future?
Shares of Pfizer PFE dropped more than 3% on Tuesday after the company announced its financial outlook for the full year 2026 ...
Population Health Partners and dacadoo Announce Strategic Partnership “We are working with dacadoobecause they are leaders in their field of health engagement with a scalable digital solution. ” said ...
Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 Revenue guidance(2) and ...
Biotech’s slump may finally be over in 2026. In interviews with BioSpace, Zymeworks’ CEO Ken Galbraith and Zai Lab’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback